机器人辅助腹腔镜人工尿道括约肌植入术治疗女性压力性尿失禁的初步单中心研究
该前瞻性单中心试点研究纳入2012至2018年间接受机器人辅助腹腔镜人工尿道括约肌(AUS)植入或翻修术的女性压力性尿失禁患者41例,中位年龄67.5岁。植入组27例中报告1例中转开腹、1例膀胱颈损伤和1例输尿管损伤,翻修组14例中报告1例肠损伤导致患者死亡及1例装置感染需取出。植入组和翻修组中位随访分别为19和18个月,控尿率分别为84%(21/25)和83.3%(10/12)。
要点
- 机器人辅助AUS植入在女性SUI中控尿率84%,翻修术控尿率83.3%。
- 植入组发生1例中转开腹、1例膀胱颈损伤和1例输尿管损伤。
- 翻修组发生1例肠损伤导致患者死亡和1例装置感染需取出。
核心结论
- 机器人辅助腹腔镜女性AUS植入术结果令人鼓舞,但既往盆腔手术导致显著并发症。
- 需要更长期随访研究。
研究设计与样本
- 前瞻性单中心试点研究,纳入2012至2018年连续女性SUI患者41例,中位年龄67.5(IQR 57-74.7)岁。
- 植入组27例,翻修组14例,均采用经腹腔机器人入路。
主要发现
- 植入组27例中,1例中转开腹,1例膀胱颈损伤,1例输尿管损伤,后两例未植入AUS。
- 植入组10例患者发生12例次Clavien-Dindo I-II级早期并发症,中位随访19(IQR 11-27)个月,控尿率84%(21/25)。
- 翻修组14例中,无阴道或膀胱损伤,1例肠损伤中转开腹未植入AUS。
- 翻修组2例发生Clavien-Dindo III-V级早期并发症:1例术中肠损伤最终导致患者死亡,1例装置感染需取出。
- 翻修组中位随访18(IQR 13.5-24.2)个月,控尿率83.3%(10/12)。
关键数值与推荐
- 控尿定义为无需使用尿垫。
- 并发症采用Clavien-Dindo分级报告。
临床怎么用
- 机器人辅助AUS植入可作为女性SUI的治疗选择,但需警惕既往盆腔手术相关并发症。
- 术后需密切监测感染及肠道损伤等严重并发症。
局限性
- 单中心试点研究,样本量有限。
- 随访时间较短。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report the functional outcomes of robot-assisted laparoscopic artificial urinary sphincter (AUS; AMS 800™, American Medical Systems, Minnetonka, MN, USA) implantation and revision in women with stress urinary incontinence (SUI). PATIENTS AND METHODS: A pilot prospective monocentric study included all consecutive female patients with SUI and undergoing an AUS surgery (implantation or revision) using a robotic approach between 2012 and 2018. The AUS was implanted through a transperitoneal robotic approach. The dissection of the bladder neck was initiated using a posterior approach with a permanent visual control. Intraoperative and early postoperative complications were reported (Clavien-Dindo classification). Continence was defined as no pad usage. RESULTS: A total of 41 patients, median (interquartile range [IQR]) age 67.5 (57-74.7) years were included. In the group of 27 patients undergoing an AUS implantation, one conversion to laparotomy, one bladder neck and one ureteric injury occurred. The AUS was not implanted in the two latest cases. Twelve minor (Clavien-Dindo Grade I-II) early postoperative complications occurring in 10 patients were reported. The median (IQR) follow-up was 19 (11-27) months. The continence rate was 84% (21/25 patients). In the group of 14 patients undergoing an AUS revision, no vaginal or bladder injury was reported. One patient had a bowel injury with conversion to laparotomy without AUS insertion. Two major (Clavien-Dindo Grade III-V) early postoperative complications occurred in two patients: one intraoperative bowel injury, which ultimately resulted in the death of the patient and one device infection requiring an explantation of the AUS. The median (IQR) follow-up was 18 (13.5-24.2) months. The continence rate was 83.3% (10/12 patients). CONCLUSION: The results obtained after robot-assisted laparoscopic AUS implantation among women are promising despite the significant morbidity due to previous pelvic surgeries. Longer follow-up studies are needed.
引用
- Chartier-Kastler E, Vaessen C, Rouprêt M, et al. Robot-assisted laparoscopic artificial urinary sphincter insertion in women with stress urinary incontinence: a pilot single-centre study. BJU Int. 2020. PMID: 32558978. doi:10.1111/bju.15147
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。